Hypoaldosteronism overview: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Hypoaldosteronism}} | {{Hypoaldosteronism}} | ||
{{CMG}} | {{CMG}} | ||
Line 17: | Line 15: | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Endocrinology]] | [[Category:Endocrinology]] | ||
[[Category:Nephrology]] | [[Category:Nephrology]] |
Revision as of 13:59, 27 September 2012
Hypoaldosteronism Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hypoaldosteronism overview On the Web |
American Roentgen Ray Society Images of Hypoaldosteronism overview |
Risk calculators and risk factors for Hypoaldosteronism overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Hypoaldosteronism refers to decreased levels of the hormone aldosterone.
There are several causes for this condition, including primary adrenal insufficiency, congenital adrenal hyperplasia, and medications (certain diuretics, NSAIDs, and ACE inhibitors).
This condition may result in hyperkalemia, which can be serious medical condition. It can also cause hyponatremia.